German Healthtech Stock News

Deutsche Post (XTRA:DHL) has put fresh numbers on the table for FY 2025, with third quarter revenue at about €20.1b and basic EPS of €0.75, giving investors an updated read on how the business is tracking through the year. The company has seen quarterly revenue move from about €23.3b in Q4 2024 to €21.1b in Q1 2025, €19.5b in Q2 2025 and €20.1b in Q3 2025, while basic EPS shifted from €0.95 to €0.68, €0.72 and then €0.75 over the same stretch, setting up a clear earnings run rate for the year...

CompuGroup Medical SE KGaA (HMSE:COP) has wrapped up its FY 2025 update with first half revenue of €593.7 million and basic EPS of €0.31, alongside net income of €16.1 million, giving investors fresh numbers to weigh against a current share price of €27.48. Over recent periods, the company has seen revenue move from €578.8 million in 1H 2024 to €607.5 million in 2H 2024 and €593.7 million in 1H 2025, while basic EPS shifted from €0.62 in 1H 2024 to €0.04 in 2H 2024 and €0.31 in 1H 2025. This...

Dürr (XTRA:DUE) has laid out a mixed set of FY 2025 numbers, with Q3 revenue of €1.0 billion and EPS of €0.36 set against a trailing 12 month EPS loss of €0.91 on revenue of about €4.2 billion. The company has seen quarterly revenue move between €1.0 billion and €1.3 billion since Q2 2024, while EPS has swung from a loss of €1.62 in Q2 2025 to positive readings of €0.24 to €0.45 in other recent quarters. Investors are therefore seeing a picture of a stable top line paired with uneven...

Infineon Technologies: recent performance and business profile Infineon Technologies (XTRA:IFX) has been drawing attention after recent share price moves, with the stock showing mixed returns over the past week, month and past 3 months, prompting investors to reassess its fundamentals. The company operates across automotive, industrial power, power and sensor systems, and connected secure systems. It reported revenue of €14,900.0m and net income of €1,003.0m, figures that help frame current...

adidas (XTRA:ADS) is back in focus after its 2025 earnings release, its cautious 2026 outlook, and a proposed higher dividend, a mix that has coincided with recent share price pressure. See our latest analysis for adidas. That reaction sits against a tough recent run, with adidas’ 7 day share price return of 9.8% and 90 day share price return of 13.1% both in negative territory. The 1 year total shareholder return of 39.1% decline and 5 year total shareholder return of 50.0% decline suggest...

PUMA (XTRA:PUM) has drawn investor attention after reporting annual revenue of €7.3b alongside a net loss of €673.9m, prompting closer scrutiny of how its global sports and lifestyle business is being reflected in the current share price. See our latest analysis for PUMA. The latest figures land against a mixed price backdrop, with PUMA’s 1 day share price return of 1% decline and 7 day share price return of 5.7% decline contrasting with a 90 day share price return of 6.2% gain. The 1 year...

Continental FY 2025 earnings snapshot Continental (XTRA:CON) has wrapped up FY 2025 with fourth quarter revenue of €4,965 million and net income from continuing operations of €13 million, while earnings from discontinued operations contributed €4 million. The company has seen quarterly revenue shift from €10,095 million in Q4 2024 to around the €4,856 million to €4,965 million range across 2025, with Basic EPS moving from €2.15 in Q4 2024 to readings between a loss of €3.78 in Q3 2025 and a...

Ströer SE KGaA (XTRA:SAX) has wrapped up FY 2025 with fourth quarter revenue of €603.3 million and net income of €65 million, setting the tone for how investors read the year as a whole. Over recent quarters the company has seen revenue move from €475.5 million in Q1 2025 to €504.7 million in Q2 and €491.5 million in Q3. Trailing twelve month revenue sits at about €2.1 billion and net income at €140 million, giving helpful context around the most recent print. With net profit margin at 6.7%...

Mercedes-Benz Group (XTRA:MBG) FY 2025 earnings snapshot Mercedes-Benz Group (XTRA:MBG) has wrapped up FY 2025 with fourth quarter revenue of €33.7b and basic EPS of €1.43, backed by net income of €1.4b. The company has seen quarterly revenue move from €38.5b and EPS of €2.57 in Q4 2024 to €33.7b and €1.43 in Q4 2025, with FY 2025 quarters ranging between €32.1b and €33.7b of revenue and EPS between €0.95 and €1.74. With trailing net margin sitting at 3.9% versus 7% a year earlier, this set...

Bayer FY 2025 earnings snapshot Bayer (XTRA:BAYN) has capped FY 2025 with a tough final quarter, posting Q4 revenue of €11.4 billion and a basic EPS loss of €3.80, alongside a net loss of €3.8 billion. Over recent periods, the company has seen quarterly revenue move between €9.7 billion and €13.7 billion, while EPS has swung from a profit of €1.32 in Q1 2025 to losses in each of the following quarters. This keeps the focus firmly on how quickly margins can stabilize. With forecasts in the...

Symrise (XTRA:SY1) shares are in focus after the company paired its 2025 results with a proposed dividend increase, a new Care & Wellness division, and a €400 million share buyback program. See our latest analysis for Symrise. At a share price of €72.68, Symrise has a 1-day share price return of 2.45% and a year to date share price return of 6.32%. However, the 1-year total shareholder return of 23.13% and 5-year total shareholder return of 24.66% show that longer term holders have faced...

Sixt (XTRA:SIX2) has moved into focus after reporting 2025 earnings, with sales of €4,282.98m and net income of €285.81m, alongside a proposed 18.5% dividend increase. See our latest analysis for Sixt. The 1-day share price return of 4.34% to €67.25 comes after record 2025 results. However, the 1-year total shareholder return of a 21.46% decline and the 3-year total shareholder return of a 39.08% decline suggest momentum has been fading despite recent earnings strength. If this earnings news...

LEG Immobilien (XTRA:LEG) has wrapped up FY 2025 with Q4 revenue of €397.3 million and basic EPS of €4.37, while its trailing twelve month figures sit at €1.58 billion of revenue and EPS of €19.44. Over recent periods, revenue has moved from €515.6 million in Q4 2024 to €468.7 million in Q1 2025, €361.7 million in Q2, €351.4 million in Q3 and €397.3 million in Q4, with quarterly EPS ranging from €0.77 to €9.08. As a result, investors are likely to focus on how these swings and the very high...

Hensoldt (XTRA:HAG) is back in focus after raising its 2026 earnings guidance, with the company now targeting around €2,750 million in revenue, along with a higher annual dividend proposal and renewed leadership commitment. See our latest analysis for Hensoldt. Despite the raised 2026 guidance and higher dividend proposal, Hensoldt’s recent news flow has coincided with pressure on the share price. A 1 month share price return of 10.69% and a 7 day share price return of 6.26% indicate that...

Merck KGaA (XTRA:MRK) is back in focus after reporting fourth quarter and full year 2025 results. The latest sales and earnings figures give investors fresh data on its Life Science, Healthcare and Electronics segments. See our latest analysis for Merck KGaA. The earnings release appears to have reset expectations, with a 1-day share price return of an 8% decline and a 1-year total shareholder return of an 18.41% decline, indicating that pressure has been building rather than easing. If Merck...

If you are wondering whether Deutsche Post's current share price still offers value or if most of the opportunity is already priced in, you are exactly who this review is written for. The stock last closed at €45.89, with a 7.9% decline over the past week and a 5.1% decline over the past month, while the 1 year and 3 year returns sit at 8.9% and 27.5% respectively. Recent news coverage has focused on Deutsche Post's role as a major global logistics and parcel provider, with attention on how...

Volkswagen (XTRA:VOW3) is facing a new class-action lawsuit in the U.S. filed by a group of its franchised dealerships. The dealers allege the company breached existing agreements by using Scout Motors to sell electric vehicles directly to consumers. The case centers on whether Scout branded EVs should pass through the traditional dealer model or a separate direct to consumer channel. For you as an investor, this dispute sits at the intersection of legacy auto retail models and newer direct...

Grand City Properties FY 2025 earnings snapshot Grand City Properties (XTRA:GYC) has wrapped up FY 2025 with Q4 revenue of €149.9 million and basic EPS of €0.79, set against a trailing twelve month net income of €511.9 million and EPS of €2.67. Over the past year, the company has seen revenue move from €597.0 million to €601.5 million on a trailing basis, while EPS shifted from €1.14 to €2.67, alongside a net profit margin of 85.1% that is influenced by a €272.5 million one off gain...

Adidas (XTRA:ADS) has just wrapped up FY 2025 with fourth quarter revenue of €6.1b and basic EPS of €0.42, capping a year in which trailing twelve month revenue reached €24.8b and EPS came in at €7.46. Over recent periods, quarterly revenue has ranged from €5.7b to €6.7b while basic EPS moved from a loss of €0.26 in Q4 2024 to €2.56 in Q3 2025, alongside trailing net profit margin of 5.4% and earnings growth of 76.2% over the last year. This sets up a results season in which investors are...

In February 2026, ZEISS Medical Technology launched ZEISS Collaborative Care, a browser-based, cloud-delivered application that lets eye care professionals securely share diagnostic data, manage referrals, and communicate in real time across different clinical settings. By sitting on the ZEISS Healthcare Data Platform and linking with ZEISS FORUM, the software effectively turns existing ophthalmic devices and data silos into a connected collaboration network for more coordinated care. We’ll...

Aroundtown (XTRA:AT1) has wrapped up FY 2025 with fourth quarter revenue of €396 million and basic EPS of €0.14, alongside trailing twelve month revenue of about €1.6 billion and EPS of €0.61. Together, these figures frame a year of sharp earnings recovery from a much weaker prior period. Over recent quarters, the company has seen revenue move from €352.1 million and EPS of €0.25 in Q4 2024 through to €390.7 million and EPS of €0.20 in Q1 2025, with Q3 2025 landing at €389.9 million and EPS...

Recently, TYTAN Technologies announced a partnership and funding round with DEUTZ, under which DEUTZ will supply and industrialise drive, battery, and energy modules for TYTAN’s drone defence systems, while also preparing to showcase its sustainable drive and energy solutions at CONEXPO Las Vegas. This move marks DEUTZ’s entry into the European unmanned defence systems market and coincides with BlackRock increasing its voting stake above the 3% threshold, highlighting growing institutional...

Bayer received preliminary court approval for a multibillion euro Roundup class action settlement, addressing a large portion of ongoing litigation. The company reported positive late stage clinical data in prostate cancer, including survival benefits for radium 223 (XOFIGO) in combination therapy and first in human data for a next generation targeted alpha therapy. The FDA cleared expanded capabilities for Bayer's MEDRAD MRXperion MR injection system in the United States. Bayer entered an...

Why BASF (XTRA:BAS) Is Back on Investors’ Radar BASF (XTRA:BAS) has moved back into focus for some investors after a period of mixed share performance, with a slight gain over the past 3 months and a negative 1 year total return. This combination of recent improvement alongside a weaker 1 year result is prompting closer attention to how the chemical group’s current valuation lines up with its earnings, cash generation, and long established global footprint. See our latest analysis for...